References
- Khardori N, Yassien MJ. Biofilms in device-related infections. Ind. Microbiol.15(3), 141–147 (1995).
- Andreas Stein, Bataille JF, Drancourt M et al. Ambulatory treatment of multidrugresistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim–sulfamethoxazole). Antimicrob. Agents Chemother.42, 3086–3091 (1998).
- Gomez J, Rodriguez M, Banos V et al. Orthopedic implant infection: prognostic factors and influence of long term antibiotic treatment on evolution. Prospective study, 1992–1999. Enferm. Infect. Microbiol. Clin.21, 232–236 (2003).
- Vinh DC, Embil JM. Device-related infections: a review. J. Long Term Eff. Med. Implants15(5), 467–488 (2005).
- Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin. Infect. Dis.33, 94–106 (2001).
- Fitzgerald RH Jr. Total hip arthroplasty sepsis, prevention and diagnosis. Orthop. Clin. North Am.23, 259–264 (1992).
- Praemer A, Furner S, Rice DP. Musculoskeletal conditions in the United States. Am. Acad. Ortop. Surg.127–141 (1992).
- Horan FC, Gaynes RP, Marton WJ et al. CDC definitions of nosocomial surgical site infections 1992: a modification of CDC definitions of surgical wound infection. Infect. Control Hosp. Epidemiol.13, 606–608 (1992).
- Steckelberg JM, Osman DR. Prosthetic joint infections. In: Infections Associated with Indwelling Medical Devices (2nd Edition). Bisno AL, Waldvogel FA (Eds). American Society for Microbiology Washington, DC, USA 59–90 (1994).
- Zimmerli W, Widmer AF, Blatter M et al. Role of rifampin for treatment of ortopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA279, 1537–1541 (1998).